Pricing

Log inSign up

Geron

4 followers

‌

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Industries

Biotechnology, Health & Wellness

Headquarters

Menlo Park, United States

Employees

201-500

Links

Org chart

John A. Scarlett
Chairman, President & CEO

John A. Scarlett

Collapse
Andrew J. Grethlein
EVP & COO
Edward Koval
EVP & Chief Business Officer
Michelle Robertson
Executive Vice President, CFO & Treasurer
Melissa A. Kelly Behrs
EVP, Business Operations & Chief Alliance Officer
Faye Feller
EVP, Chief Medical Officer
Jim Ziegler
EVP & Chief Commercial Officer
Scott A. Samuels
EVP, CLO & Corporate Secretary
Nishan Sengupta
Vice President-market Access, Pricing, Evidence Strategy
Scott Hutson
Vice President Of Sales
Ryan Vincenti
Associate Director Of Commercial Excellence

Board & advisors

Dawn C. Bir
Director
Elizabeth G. O'Farrell
Director
Robert J. Spiegel
Director
Susan M. Molineaux
Director
V. Bryan Lawlis
Director
John F. McDonald
Independent Director
Gaurav Aggarwal
Director

Teams

+16

Directors

19 members

+11

Clinical Operations Team

14 members

+8

Medical and Clinical Teams

11 members

+2

Leadership Team

5 members

+3

Business Operations Team

6 members

+3

Human Resources Team

6 members

Offices

Similar companies

Roivant Sciences

56 followers

Beam

9 followers

Schrödinger

8 followers

ElevateBio

5 followers

Alector

3 followers

Headway

21 followers

Nurix

3 followers

BioAgilytix

2 followers

ImmunityBio

2 followers

Avid Bioservices

2 followers

Allogene Therapeutics

1 follower

Explore companies